Valacyclovir and Ranolazine drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Valacyclovir (valacyclovir hydrochloride) and Ranolazine (ranolazine). Common drug interactions include breast cancer among females and insomnia among males.
The phase IV clinical study analyzes what interactions people have when they take Valacyclovir and Ranolazine. It is created by eHealthMe based on reports of 27 people who take the same drugs from the FDA, and is updated regularly.
What is Valacyclovir?
Valacyclovir has active ingredients of valacyclovir hydrochloride. It is often used in genital herpes. eHealthMe is studying from 42,107 Valacyclovir users. Check the latest studies of Valacyclovir.
What is Ranolazine?
Ranolazine has active ingredients of ranolazine. eHealthMe is studying from 9,939 Ranolazine users. Check the latest studies of Ranolazine.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
27 people who take Valacyclovir and Ranolazine together, and have interactions are studied.

What are the common drug interactions of Valacyclovir and Ranolazine, by gender? *:
female:
- Breast cancer
- Pneumonia
- Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
- Infusion site extravasation (flow of (blood or lymph) from infusion site)
- Metabolic disorder (an abnormal function and pattern of body fat. insulin resistance refers to the diminished ability of cells to respond to the action of insulin in promoting the transport of the sugar glucose, from blood into muscles and other tissues)
- Respiratory distress (difficulty in breathing)
- Platelet count decreased
- Visual impairment
- Aphasia (damage to the parts of the brain that control language)
- Balance disorder
male:
- Insomnia (sleeplessness)
- Blood pressure increased
- Eye irritation
- Eye pain
- Facial pain
- Fatigue (feeling of tiredness)
- Immunodeficiency
- Influenza
- Memory impairment
- Neuropathy peripheral (surface nerve damage)
What are the common drug interactions of Valacyclovir and Ranolazine, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
- Confusional state
- Dysarthria (speech disorder)
- Facial paralysis (loss of function of face muscle)
- Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
- Muscular weakness (muscle weakness)
- Progressive multifocal leukoencephalopathy (rapidly progressive neuromuscular disease caused by opportunistic infection of brain cells)
- Pyelonephritis (inflammation of kidney caused by bacteria)
- Pyrexia (fever)
- Urinary tract infection
50-59:
n/a
60+:
- Bradycardia (abnormally slow heart action)
- Diarrhoea
- Immunodeficiency
- Influenza
- Insomnia (sleeplessness)
- Neuropathy peripheral (surface nerve damage)
- Obesity (having too much body fat)
- Ocular hyperaemia (an abnormally large amount of blood in eye)
- Pain
- Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
What are the existing conditions these people have? *
- Multiple Myeloma (cancer of the plasma cells): 11 people, 40.74%
- Type 1 Diabetes: 6 people, 22.22%
- Stable Angina (a constant chest pain): 5 people, 18.52%
- Chronic Kidney Disease: 5 people, 18.52%
- Pain: 4 people, 14.81%
- Nausea (feeling of having an urge to vomit): 4 people, 14.81%
- Rashes (redness): 2 people, 7.41%
- High Blood Pressure: 2 people, 7.41%
- Coronary Heart Disease (narrowing or blockage of the coronary arteries): 2 people, 7.41%
- Blood Testosterone Decreased: 2 people, 7.41%
* Approximation only. Some reports may have incomplete information.
Do you take Valacyclovir and Ranolazine?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Valacyclovir (42,107 reports)
- Ranolazine (9,939 reports)
Browse all drug interactions of Valacyclovir and Ranolazine:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Valacyclovir:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Ranolazine:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Valacyclovir and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Ranolazine and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on valacyclovir hydrochloride and ranolazine (the active ingredients of Valacyclovir and Ranolazine, respectively), and Valacyclovir and Ranolazine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Psoriasis and Injection Site Extravasation - 5 seconds ago
- Depression and Stress Cardiomyopathy - 20 seconds ago
- Fluvastatin Sodium vs. Metoprolol Tartrate, side effect and effectiveness comparison - 24 seconds ago
- Nosebleed in Zyrtec, how severe and when it was recovered? - 37 seconds ago
- Drug interactions of Praluent and Baby Aspirin - 43 seconds ago
- Could Ketoconazole cause Foot Deformity? - 44 seconds ago
- Could Fludrocortisone Acetate cause Weakness? - 50 seconds ago
- Drug interactions of Diovan Hct and Diovan - 50 seconds ago
- Excedrin and Ibu drug interactions for women aged 60+ - 55 seconds ago
- Could Dimetapp cause Ischaemic Stroke? - a minute ago